The ORR and DCR of the first and second generation TKI for EGFR mutation positive non-squamous non-small cell lung cancer (NSq-NSCLC) were about 56.0%-71.2% and 90.0%-91.7%, respectively (23, 47). The gene discussed is EGFR; the disease is non-small cell squamous lung carcinoma.